 Primary metastatic breast carcinoma initial clinical evaluation PET glucose analogue authors breast cancers means positron emission tomography PET positron-emitter-labeled glucose analogue FDG patients primary and/or metastatic breast cancer PET images distribution vivo hour intravenous injection mCi FDG Scan findings data physical examination biopsy results primary breast cancers means FDG PET tumor background FDG ratio median bone metastases tumor normal bone uptake ratio median soft-tissue metastases unsuspected nodal lesions PET false-positive foci FDG uptake cases negative mammograms due breast parenchyma FDG PET primary tumors preliminary data feasibility substantial potential PET FDG primary metastatic breast cancers